You are here

  • Home
  • Archive
  • Volume 21, Issue 3
  • Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer: A Phase Ib Study

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer: A Phase Ib Study

 

Online download statistics by month:

Online download statistics by month: April 2019 to March 2023

AbstractFullPdf
Apr 20191601
May 20193002
Jun 20191400
Jul 20192000
Aug 20192601
Sep 20193202
Oct 20191400
Nov 20191800
Dec 20191301
Jan 20203600
Feb 20203600
Mar 2020800
Apr 2020900
May 20202401
Jun 20201000
Jul 20201600
Aug 20202800
Sep 20201600
Oct 20201001
Nov 2020601
Dec 2020600
Jan 20212800
Feb 20212300
Mar 20211300
Apr 20212400
May 20212000
Jul 2021100
Sep 2021001
Oct 20211801
Nov 2021800
Dec 20211500
Jan 20221200
Feb 20223400
Mar 20222800
Apr 20221400
May 20224200
Jun 20225000
Jul 20223200
Aug 20224400
Sep 20223200
Oct 20224300
Nov 20222800
Dec 20222601
Jan 2023800
Feb 20238401
Mar 2023201
Total1017015